BMA Stock Banco Macro SA (BMA, $89.94) Moving Average Convergence Divergence (MACD) Histogram turned positive on December 10, 2025

GET DAILY SIGNALS

Get AI intraday signals

BMA - Banco Macro SA

MACD signal

View

Odds of UP Trend

Price: $89.94

Daily change: +$3.16 (+3.64%)

Daily volume: 255.2K

Capitalization: $5.7B

Industry: Regional Banks

This is a Bullish indicator signaling BMA's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 43 similar cases where BMA's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

BMA's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for BMA turned positive on December 10, 2025. Looking at past instances where BMA's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 28, 2025. You may want to consider a long position or call options on BMA as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for BMA moved above the 200-day moving average on December 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMA advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

BMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for BMA moved out of overbought territory on November 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BMA entered a downward trend on December 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 52, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.729) is normal, around the industry mean (1.161). P/E Ratio (21.670) is within average values for comparable stocks, (18.793). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.266). Dividend Yield (0.020) settles around the average of (0.035) among similar stocks. P/S Ratio (2.602) is also within normal values, averaging (5.329).